Summary
This CLE session will cover current developments in Section 337 investigations before the ITC. Our discussion will cover significant developments relating to public interest issues arising in investigations pertaining to pharma and medical devices and new trends in non-patent based investigations, including antitrust, trade secret, and false advertising based investigations. We will also cover the latest updates regarding the interplay between Section 337 investigations and IPRs.
Darryl Woo, Mark Davis and PJ McCarthy will be speaking at this event.
Speakers
- /en/people/w/woo-darryl
Darryl M. Woo
Partner